| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.00049 | 1 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.00033 | 1 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.00026 | 1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.00027 | 1 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.00024 | 1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.00023 | 1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.00018 | 1 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 9.1e-05 | 1 |